Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer

Total Raised

$7M

Investors Count

1

Deal Terms

1

Anexon Funding, Anexon Valuation & Anexon Revenue

1 Fundings

Anexon's latest funding round was a Series A for $7M on October 26, 2010.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/26/2010

Series A

$7M

Date

10/26/2010

Round

Series A

Amount

$7M

Investors

Valuation

Revenue

Sources

Anexon Deal Terms

1 Deal Term

Anexon's deal structure is available for 1 funding round, including their Series A from October 26, 2010.

Round

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

$99M

Dividend Rate

$99M

Liquidation Preferences

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Anexon Investors

1 Investors

Anexon has 1 investors. Mayo Clinic invested in Anexon's Series A funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/26/2010

10/26/2010

1
Series A

Non-Profit Foundation

Minnesota

First funding

10/26/2010

Last Funding

10/26/2010

Investor

Rounds

1
Series A

Board Seats

Type

Non-Profit Foundation

Location

Minnesota

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.